John Achoukian, MHI, PMP’s Post

What does the Panalgo + Atropos Health partnership mean for life sciences organizations? We spoke with Panalgo’s General Manager, Kevin D'Ambrosia, to find out how the partnership helps life sciences organizations get better speed to insights and harness the power of #GenAI. Read the blog: https://lnkd.in/gGwH89cf

April is National Minority Health Month, and at Inovalon, we're committed to bridging health disparities and advancing equity for all. Data has shown that minority groups are often underserved by the healthcare system – and data is key to making real change in health equity. With our industry-leading primary source dataset, we are expanding diversity in clinical trials and better informing minority patient care by accounting for social drivers of health. Inovalon's dataset represents the largest, most diverse resource for researchers and analysts across healthcare to derive deep insights for the improvement of health outcomes and economics. Our latest research with Harvard Medical School is a good example. You can download the 4 research papers here: https://ow.ly/sEI330sBrCq I am proud to work for a company that is contributing to advancements in health equity. While National Minority Health Month reminds us that healthcare has work left to do to deliver equal care to all communities, we’re also reminded of how far the healthcare system has come. #MinorityHealthMonth #HealthEquity

I feel thrilled and proud to share that an article I co-authored with my BCG X colleagues, Chris Meier, Nigel Markey, Ben Howitt, Ilyass El Mansouri, and Carel Schwartzenberg, has been published in the esteemed Nature Scientific Reports. Do clinical trials keep getting more complex? Over 16,000 trial data sets analysed through machine learning by us signal a strong yes! The last decade witnessed a sea of changes in clinical trials - new formats, endpoints, regulatory shifts, and escalating competition. Meanwhile, trials take longer, and success rates feel like a trip up the down escalator. An urgent question: Is clinical trial complexity spiralling uncontrollably? And is such complexity necessary? Curious? Immerse yourself in the details here: https://lnkd.in/e-bRacYz #Nature #Healthcare #BCGX

Looking forward to this morning's Healthcare Entrepreneur Meetup Session! Networking followed by Founder presentations: 1.     Courtney Richards – DMEconnected: The fastest & easiest way to get patients Home Medical Equipment, Services, and Therapy they need, when they need it. 2.     Christine Nicodemus – Wayhaven: Empowering students with 24/7 mental wellness support, fostering success and resilience in college life. 3.     Gerald Carter – Destined AI: AI first platform: combating biases in AI through good data. 4.     Blake Stoner – The Vngle Grassroots News Agency: Various angles of nonpartisan coverage. We mobilize creators to help combat underrepresentation & misinformation. Highlighting recent work in healthcare.

💡 Dr. Brian Covino, Cohere Health's Chief Medical Officer, penned a new piece for Answers Media Network on harnessing AI-powered prior authorization to unlock equitable care: https://lnkd.in/gywdYqSc 👉 Dr. Covino explores the importance of SDOH data and three key ways that intelligent prior authorization can advance health equity.

📯 #CallforPapers Are you working on #digitalhealth or #medicalAI? Send us your abstract to our @FrontiersinSociology special issue on #ParticipatoryGovernance #AlgorithmicFairness and #SocialJustice 🧐 Editors: Cláudia de Freitas Kira Allmann, Ph.D. Vera Lucia RAPOSO Simeon Yates and Carlo Botrugno More details 👉 https://lnkd.in/dmcNqbzZ   💥 Themes of interest include: • Digital health governance gaps, public (dis)trust in digital health, and data diversity deficits • The social, ethical, legal, and personal implications of algorithmic decision-making, including how algorithmic biases are uncovered, exposed, and resisted during algorithmic training and up to the point of care (e.g. in clinical settings) • The disruption, (re)shaping or transformation of patterns of exclusion through digital health technologies and services • The emergence of new forms of advocacy, community mobilization, participation, and citizenship linked to health digitization and the (re)production of inequalities • Opportunities, tensions, and limits to public involvement in digital health governance • Participatory approaches to digital health technologies’ design, implementation, usage, and adaptation. 🙌 Looking forward to reading from you!

Think it's too early to think about a study? Enjoyed my chat today with another inspiring, incredibly promising start-up. Thanks for letting me share!   "We are a pre-growth company trying to get our heads around our initiatives and what to prioritize. The Sales-Focused Clinical Study webinar was super helpful for us. It was great to hear thought leaders highlighting things we should be thinking of early in terms of avoiding pitfalls!"     - Co-Founder UK Based Behavioral Health Digital Solution Thinking through the design of a clinical study early can help you recognize your gaps in product development or market research. Even for the earliest of stage companies. 𝐒𝐨 𝐰𝐡𝐚𝐭 𝐰𝐞𝐫𝐞 𝐭𝐡𝐨𝐬𝐞 𝐩𝐢𝐭𝐟𝐚𝐥𝐥𝐬? Building a product without defining your dream customer, claiming to be too many things to too many people, not knowing your regulatory strategy early in product development, appealing to early adopters but never beyond Manos Health Rishab Shah Ben Rosner, MD, PhD

💡 There's something we believe very strongly in at Humanity Inc: 💯 Everyone should be able to access and understand their Biological Age (functional age based on current disease risk versus chronological age) and be able to easily track it over time. 📈 Why? Because this knowledge can inspire healthier choices and guide us towards healthier, longer lives. 🤝 That’s why I’m excited to announce our partnership with Expand Health. 🔗 Through the Humanity Inc Age API, Expand Health can seamlessly integrate biological age tracking in to their testing management platform so that it's accessible by their patients, practitioners and partners - supercharging their healthspan-focused care. ✨ We couldn’t ask for more mission-aligned partners than Emilian Popa, Jack H., and their team, including Tessa Glyn. 🙏 Special thanks to Longevity.Technology and Eleanor Garth for sharing this milestone with the community. 👏 Lastly, a huge shoutout to Henry Whicheloe, Michael D. Geer, and the entire Humanity Inc team for delivering something so impactful and scalable in such a short timeframe. Amazing work guys! 👇 Want to discover your Biological Age? Let me know in the comments below, where you will also find a link to the Longevity.Technology article announcing this strategic partnership. #humanity #longevity #healthspan #biologicalage #rateofaging

Amid the growing buzz around digital therapeutics, AI, and countless point solutions, it's essential to remember that the heart of the patient-provider relationship is trust—trust that is nurtured through longitudinal, relationship-based care. This enduring foundation is what lifestyle medicine is built upon, and it holds the potential to drive the Quintuple Aim of healthcare: enhancing patient experience, improving population health, reducing healthcare costs, supporting care team well-being, and advancing health equity. #lifestylemedicine American College of Lifestyle Medicine

These are four great insights for implementing #transformation. Thank you Patrick McGill, MD MBA. I would add when going into new technologies like #AI, we have learned it is critical to more deeply define the problem to be solved - too often healthcare leaders fall in love with technologies or solutions instead of problems. Additionally, implementations don't fail because vendors or partners don't do the handful of things they promised - it's because the health system did not identify or address the myriad of workflow, technical and change issues inside the health system. Reciprocating with internal resources do this important work is critical to success.